CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.

Abstract

No abstract available.

Authors
  • Bertagnolli MM
  • Dzieciatkowski S
  • Emond MJ
  • Foster NR
  • Goldberg RM
  • Grady WM
  • Lao VV
  • Luo Y
  • Maizels N
  • Monnat RJ
  • Nam E
  • Niedzwiecki D
  • Renfro LA
  • Saltz LB
  • Shiovitz S
  • Venook A
  • Warren RS
PubMed ID
Appears In